Use of mitoxantrone in neuromyelitis optica.

Use of mitoxantrone in neuromyelitis optica.

Detalhes bibliográficos
Main Authors:	Kitley, J, Leite, M, Matthews, L, Palace, J
Formato:	Journal article
Idioma:	English
Publicado em:	2011

Registos relacionados

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort
Por: Leonard, H, et al.
Publicado em: (2012)

The borderland of neuromyelitis optica.
Por: Matthews, L, et al.
Publicado em: (2009)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Por: Kitley, J, et al.
Publicado em: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
Por: Kitley, J, et al.
Publicado em: (2014)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
Por: Kitley, J, et al.
Publicado em: (2012)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
Por: George, J, et al.
Publicado em: (2012)

Seasonal pattern of variation in neuromyelitis optica relapses
Por: Elsone, L, et al.
Publicado em: (2012)

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE
Por: Kitley, J, et al.
Publicado em: (2012)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
Por: Luppe, S, et al.
Publicado em: (2012)

A clinical/immunological neuromyelitis optica association study
Por: Kitley, J, et al.
Publicado em: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
Por: Matthews, L, et al.
Publicado em: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
Por: Matthews, L, et al.
Publicado em: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Por: Kitley, J, et al.
Publicado em: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
Por: Collongues, N, et al.
Publicado em: (2013)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
Por: Kitley, J, et al.
Publicado em: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
Por: Elsone, L, et al.
Publicado em: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
Por: Waters, P, et al.
Publicado em: (2015)

A practical guide to the treatment of neuromyelitis optica.
Por: Palace, J, et al.
Publicado em: (2012)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
Por: Jacob, A, et al.
Publicado em: (2012)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
Por: Kitley, J, et al.
Publicado em: (2014)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
Por: Kitley, J, et al.
Publicado em: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Por: Kitley, J, et al.
Publicado em: (2013)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
Por: Kim, W, et al.
Publicado em: (2012)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
Por: Kitley, J, et al.
Publicado em: (2013)

CAN MRI BE USED AS A DIAGNOSTIC TOOL IN NEUROMYELITIS OPTICA SPECTRUM DISORDER?
Por: Matthews, L, et al.
Publicado em: (2012)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
Por: Kitley, J, et al.
Publicado em: (2011)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
Por: Nour, M, et al.
Publicado em: (2014)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
Por: Absoud, M, et al.
Publicado em: (2014)

Magnetic resonance imaging in neuromyelitis optica.
Por: Tackley, G, et al.
Publicado em: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
Por: Kitley, J, et al.
Publicado em: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
Por: Kitley, J, et al.
Publicado em: (2014)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
Por: Kitley, J, et al.
Publicado em: (2012)

The evolving clinical spectrum of neuromyelitis optica
Por: Viegas, S, et al.
Publicado em: (2008)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
Por: Fujihara, K, et al.
Publicado em: (2014)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
Por: Downer, J, et al.
Publicado em: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
Por: Downer, J, et al.
Publicado em: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
Por: Viegas, S, et al.
Publicado em: (2009)

Treatment of Neuromyelitis Optica: Review and Recommendations.
Por: Kimbrough, D, et al.
Publicado em: (2012)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
Por: Elsone, L, et al.
Publicado em: (2013)

A mathematical model of cellular swelling in Neuromyelitis optica
Por: Laranjeira, S, et al.
Publicado em: (2017)